A detailed history of Deutsche Bank Ag\ transactions in Surmodics Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 24,012 shares of SRDX stock, worth $914,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,012
Previous 5,963 302.68%
Holding current value
$914,617
Previous $250,000 272.4%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$38.47 - $42.24 $694,345 - $762,389
18,049 Added 302.68%
24,012 $931,000
Q2 2024

Aug 14, 2024

SELL
$25.39 - $42.1 $1.15 Million - $1.91 Million
-45,399 Reduced 88.39%
5,963 $250,000
Q1 2024

May 15, 2024

SELL
$27.44 - $35.56 $1.86 Million - $2.41 Million
-67,770 Reduced 56.89%
51,362 $1.51 Million
Q4 2023

Feb 14, 2024

BUY
$28.47 - $38.49 $3.19 Million - $4.31 Million
112,055 Added 1583.37%
119,132 $4.33 Million
Q3 2023

Nov 09, 2023

BUY
$28.28 - $38.36 $31,334 - $42,502
1,108 Added 18.56%
7,077 $227,000
Q2 2023

Aug 14, 2023

SELL
$17.67 - $31.31 $116,639 - $206,677
-6,601 Reduced 52.51%
5,969 $186,000
Q1 2023

May 15, 2023

BUY
$17.13 - $38.52 $97,932 - $220,218
5,717 Added 83.42%
12,570 $286,000
Q4 2022

Feb 13, 2023

BUY
$29.44 - $37.31 $3,503 - $4,439
119 Added 1.77%
6,853 $233,000
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $25,408 - $34,288
-881 Reduced 11.57%
6,734 $205,000
Q2 2022

Aug 11, 2022

SELL
$33.25 - $45.11 $10,706 - $14,525
-322 Reduced 4.06%
7,615 $284,000
Q1 2022

May 13, 2022

SELL
$40.68 - $49.72 $35,798 - $43,753
-880 Reduced 9.98%
7,937 $360,000
Q4 2021

Feb 11, 2022

BUY
$43.21 - $57.6 $19,660 - $26,208
455 Added 5.44%
8,817 $424,000
Q3 2021

Nov 04, 2021

SELL
$52.8 - $60.32 $29,304 - $33,477
-555 Reduced 6.22%
8,362 $465,000
Q2 2021

Aug 11, 2021

SELL
$51.29 - $59.15 $22,772 - $26,262
-444 Reduced 4.74%
8,917 $483,000
Q1 2021

May 13, 2021

SELL
$42.18 - $56.07 $1.29 Million - $1.72 Million
-30,624 Reduced 76.59%
9,361 $524,000
Q4 2020

Feb 16, 2021

BUY
$35.18 - $43.52 $89,638 - $110,888
2,548 Added 6.81%
39,985 $1.74 Million
Q3 2020

Nov 12, 2020

SELL
$37.98 - $48.72 $45,538 - $58,415
-1,199 Reduced 3.1%
37,437 $1.46 Million
Q2 2020

Aug 13, 2020

SELL
$31.07 - $44.74 $2.88 Million - $4.15 Million
-92,736 Reduced 70.59%
38,636 $1.67 Million
Q1 2020

May 14, 2020

BUY
$22.46 - $42.24 $1.77 Million - $3.33 Million
78,776 Added 149.78%
131,372 $4.38 Million
Q4 2019

Feb 14, 2020

SELL
$39.01 - $47.51 $105,912 - $128,989
-2,715 Reduced 4.91%
52,596 $2.18 Million
Q3 2019

Nov 14, 2019

SELL
$38.66 - $47.41 $1.1 Million - $1.35 Million
-28,563 Reduced 34.05%
55,311 $2.53 Million
Q2 2019

Aug 14, 2019

SELL
$38.23 - $47.43 $3.7 Million - $4.58 Million
-96,668 Reduced 53.54%
83,874 $3.62 Million
Q1 2019

May 15, 2019

BUY
$41.26 - $58.35 $3.19 Million - $4.52 Million
77,399 Added 75.04%
180,542 $7.85 Million
Q4 2018

Feb 14, 2019

SELL
$44.93 - $73.38 $5.26 Million - $8.59 Million
-117,069 Reduced 53.16%
103,143 $4.87 Million
Q3 2018

Dec 21, 2021

BUY
$56.85 - $80.35 $8.85 Million - $12.5 Million
155,669 Added 241.19%
220,212 $16.4 Million
Q3 2018

Nov 14, 2018

SELL
$56.85 - $80.35 $447,352 - $632,274
-7,869 Reduced 10.87%
64,543 $4.82 Million
Q2 2018

Apr 21, 2020

BUY
$35.85 - $57.05 $969,061 - $1.54 Million
27,031 Added 59.56%
72,412 $4 Million
Q2 2018

Aug 14, 2018

SELL
$35.85 - $57.05 $182,333 - $290,156
-5,086 Reduced 10.08%
45,381 $2.5 Million
Q1 2018

Oct 18, 2019

BUY
$27.0 - $38.5 $857,817 - $1.22 Million
31,771 Added 169.93%
50,467 $1.92 Million
Q1 2018

May 15, 2018

SELL
$27.0 - $38.5 $821,421 - $1.17 Million
-30,423 Reduced 61.94%
18,696 $710,000
Q4 2017

Feb 14, 2018

BUY
$28.0 - $33.2 $110,012 - $130,442
3,929 Added 8.69%
49,119 $1.37 Million
Q3 2017

Nov 14, 2017

BUY
$24.5 - $31.1 $1.11 Million - $1.41 Million
45,190
45,190 $1.4 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.